ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 31 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,000 | -14.3% | 33,000 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | -50.0% | 33,000 | +43.5% | 0.00% | – |
Q4 2021 | $14,000 | -33.3% | 23,000 | 0.0% | 0.00% | – |
Q3 2021 | $21,000 | -30.0% | 23,000 | 0.0% | 0.00% | – |
Q2 2021 | $30,000 | -6.2% | 23,000 | 0.0% | 0.00% | – |
Q1 2021 | $32,000 | +39.1% | 23,000 | +27.8% | 0.00% | – |
Q4 2020 | $23,000 | -14.8% | 18,000 | 0.0% | 0.00% | – |
Q3 2020 | $27,000 | -15.6% | 18,000 | -10.0% | 0.00% | – |
Q2 2020 | $32,000 | +190.9% | 20,000 | +81.8% | 0.00% | – |
Q1 2020 | $11,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
Perceptive Advisors | 132,300 | $929,000 | 0.03% |
Fosun International Ltd | 29,877 | $209,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |